One Media iP Group Plc
("One Media" or the "Company")
Revised Notice of Results
One Media iP Group Plc (AIM: OMIP), the digital music rights acquirer, publisher and distributor, announces that, further to the announcement of 30 November 2021, due to a number of Covid cases impacting Company and audit resources, the Company now expects the publication of its full year results in the second half of April 2022.
-Ends-
The person who arranged the release of this information is Michael Infante, Chief Executive Officer of the Company.
| One Media iP Group Plc | +44 (0)175 378 5500 |
| Cairn Financial Advisers LLP (Nominated Adviser) | +44 (0)20 7213 0880 |
| Cenkos Securities plc (Broker) Giles Balleny Max Gould Michael Johnson (Sales)
Pete Flatt / PPR Publicity | +44 (0)20 7397 8900
+44 (0)7930 304301
|
About One Media iP Group Plc
One Media is a digital music rights acquirer, publisher and distributor. The Group specialises in purchasing and monetising intellectual property rights with proven, repeat income streams. One Media adds value to its content by maximising its availability in over 600 digital stores globally, including Apple Music, YouTube, Amazon and Spotify.
One Media's music is also widely used for synchronisation in film and TV whilst its video content is primarily viewed on YouTube where One Media operates over 20 YouTube channels as a certified partner. Additionally, its www.tcat.media copyright infringement and digital music audit tool software TCAT, is used daily with major record labels and the world leading digital international distributor. Men & Motors its branded car channel is now available via YouTube www.youtube.com/channel/UCNLiybn_9jgQaV0NZlSRwCg
One Media is listed on the London Stock Exchange on the AIM index, under the symbol 'OMIP'.
For further information, please visit www.omip.co.uk and www.harmonyip.com/
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
